420 with CNW — Research Finds Off-Duty Cannabis Use Has No Effect on Productivity

The cannabis industry is without a doubt one of the fastest-growing industries. After decades of prohibition, attitudes toward the controversial plant are changing, with 35 states legalizing medical cannabis and 15 states allowing recreational use. Still, many employers worry that cannabis use, even while off the clock, can reduce employee performance, ultimately impacting the bottom line.

According to recent research, however, there is no correlation between off-duty cannabis use and reduced productivity at work. First published in May 2020, the study sought to determine how using cannabis at different times of the day affected people’s ability to meet their job requirements as well as their behavior and attitude towards their colleagues and work respectively. Despite cannabis’ infamy, the plant is one of the most-used drugs in the country, with an estimated 20% of Americans thought to have used it in their lifetime.

Cannabis is known to reduce anxiety and induce relaxation without a morning hangover, making it perfect for unwinding after a day at work. Most cannabis drug tests check for metabolites, which are chemicals that remain in the body long after the drug breaks down. This means that an employee can fail a drug test and be penalized for cannabis they consumed over the weekend or even a week ago.

In the study, 281 employees who used cannabis and 281 direct supervisors participated. The employees were asked to report how frequently they used cannabis over the past 12 months. Specifically, they were asked questions regarding a number of parameters, such as in a timeframe of two hours before they started their work shifts, how often they used marijuana in the past 12 months during their workday, and how often they used the substance over the past year in a duration not exceeding two hours of leaving work. The supervisors were asked to observe as well as evaluate their subordinates’ performance.

The researchers found that using cannabis before and even during work negatively impacted employee productivity, as expected. Cannabis use reduced \concentration and ability to solve problems and effectively carry out tasks as well as an employee’s tendencies to assist other employees and function cohesively in a team. Cannabis use before and during work also increased employees’ propensity for counterproductive behavior, such as excessive daydreaming.

However, using cannabis after work did not impact employees’ ability to complete their assignments the next day nor their ability to relate cordially and professionally with their workmates. Unlike alcohol, employees who used cannabis after work did not exhibit reduced productivity nor an increased propensity for unproductive behavior the next day.

Pac Roots Cannabis Corp. (CSE: PACR) is a company you need to watch in the marijuana industry. This Canadian marijuana company focuses on producing high-end products and strains using carefully selected genetics.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Maine Medical Cannabis Dispensary Chain Applies to Join Residency Court Case

Last week, Wellness Connection filed a motion to protest a lawsuit against the state of Maine, which was launched by two small marijuana businesses over recreational marijuana licenses that were awarded to out-of-state firms.

Wellness Connection, which is controlled by Delaware-based investor High Street Capital Partners, manages four medical marijuana dispensaries in Maine. The recreational marijuana market in Maine is relatively new, having launched on October 9 of this year. Despite its youth, the market is expected to soon eclipse the medical cannabis market size, with total sales projected to be $76 million this year; adult-use cannabis sales making up $20 million of that amount.

By 2025, it is projected that sales will grow almost four times as high, to $295 million, with adult-use marijuana sales dominating the market sales with $265 million. The cannabis business also promoted the growth of cottage industries such as tourism.

Earlier in March, Wellness Connection sued the state of Maine over a legislation that restricted cannabis businesses with out-of-state owners from participating in the adult-use market. The company dropped the case, however, after the state confirmed that it would not be enforcing the law, which required every manager, director or officer of an adult-use marijuana business to be a resident of Maine and file taxes in the state for at least a four-year period. The state gave the reason that the residency requirement would not hold up in court.

The new motion was filed by the company on behalf of its adult-use business, NPG, in a bid to get the lawsuit of the two medical cannabis caregivers thrown out of court. The caregivers claim that the state cannot decline to enforce the law that restricts out-of-state business owners from setting up shop in the state. This is despite the state eliminating the residency requirement in May of this year.

The new motion puts the state and Wellness Connection on the same side as defendants, which is ironic. The company is currently working on converting its medical cannabis business into an adult-use cannabis business, as its executives believe the latter is more lucrative.

In its earlier lawsuit, Wellness Connection claimed that the requirement hindered the company from raising the funds that would facilitate the transition. Currently, NPG holds an active cultivation license for adult-use cannabis, an active manufacturing license and an additional five conditional approvals for four dispensaries and another manufacturing facility.

One interesting cannabis industry sector player you should watch is Pac Roots Cannabis Corp. (CSE: PACR). This company selectively breeds high-end strains of cannabis in order to make premium products for the Canadian market and its international partners.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Pac Roots Cannabis Corp (CSE: PACR) Stands to Benefit from U.S. Potential for Cannabis Decriminalization

  • Upcoming U.S. elections has potential to radically alter state of U.S. cannabis industry
  • Democratic Vice-Presidential candidate Kamala Harris stated that potential Biden administration would seek to decriminalize use of cannabis
  • Five states will vote on legalizing recreational or medical use of marijuana this November
  • Canadian cannabis producers have benefited from experiences gleaned from operating over last two years under Canada’s existing legal framework for cannabis industry
  • Pac Roots Cannabis has taken number of steps to ensure end product quality, helping boost company’s competitiveness if U.S. cannabis industry decriminalization comes to fruition

For Pac Roots Cannabis (CSE: PACR) and the rest of the Canadian cannabis industry, the upcoming U.S. elections promise to help determine the sector’s fortunes going forward. Polls carried out in the U.S. have shown that over 66% of the population favor legalizing marijuana—a figure illustrating a meteoric rise over the past decade, having increased by 30 percentage points since 2005 (https://cnw.fm/c9dis). The growing level of support for the decriminalization of cannabis has also spilled into the political arena, with Republican lawmakers having sponsored marijuana legislation and co-chaired, along with Democrats, the U.S. Congress’s Cannabis Caucus (https://cnw.fm/N3lw8).

Meanwhile, Democratic vice-presidential nominee Senator Kamala Harris has publicly affirmed that a potential Democratic administration would seek to ‘decriminalize the use of marijuana’ (https://cnw.fm/VHDfY)– a policy which could results in significant gains for the legal Canadian cannabis industry.

However, the positive currents buoying the industry are not solely predicated on a Democratic administration being in place, with restrictions potentially being lifted even if President Trump is re-elected and Republicans keep control of the Senate. Five states are set to vote on legalizing recreational or medical marijuana in November, including New Jersey and Arizona (https://cnw.fm/nuUTn). A successful vote in favor of the measure in all five states could result in estimated sales of up to $400 million in each state in just the first year, according to the Marijuana Business Daily (https://cnw.fm/6FTcB) and would make the medical use of marijuana legal in 38 states with adult-use permitted in 14 of those, including Washington D.C.

A move towards full legalization would unlock the world’s largest cannabis market, with Canadian producers possessing a significant edge in the race to conquer the new market. With the Canadian legalized cannabis market now over two years in the making, CEO of Aurora Cannabis Miguel Martin noted that the country’s marijuana industry had gained valuable experience, which could hold them in good stead in the event of US legalization.

“Those lessons on manufacturing, labelling, sales and marketing, all of those principles … will be very applicable to the U.S. market,” he said.

Pac Roots Cannabis has recently undertaken a number of steps designed to help ensure the quality of its product, measures which should boost the company’s profile and competitiveness in the event of a fully legalized US market. The Company has sought to leverage upon the exceptional genetics of its specialized cultivars as well as an innovative proprietary cultivation technique to ensure the production of extremely high-quality strains.

More recently, the Company announced its entrance into a strategic licensing agreement with Phenome One Corp (https://cnw.fm/OtYx4) –a venture which would provide Pac Roots Cannabis with access to one of Canada’s largest live, genetic cannabis libraries with lab and field-tested, selectively bred seedlings which the Company has employed to grow, breed and clone for its own unique brands. The partnership has enabled Pac Roots to offer customers a remarkable portfolio of over 350 meticulously-designed cultivars, ranging from CBD-dominant plants with rare terpene profiles to plants with over 30% THC-content as well as West Coast outdoor, botrytis-resistant cultivars.

A recent study carried out by Data Bridge Market Research found that the value of the global legal cannabis industry was set to soar to an estimated $90 billion per annum by 2027 – while only representing 10% of annual tobacco sales around the world, the figure represents a significant uplift to the $17.7 billion worth of the industry in 2019 (https://cnw.fm/C2Vda). In the event that the US market shifts towards decriminalizing the use of recreational cannabis, the projected figures could be set to soar – along with the fortunes of companies like Pac Roots Cannabis and its peers.

For more information on Pac Roots Cannabis Corp., visit the company’s website at www.PacRoots.ca

NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://cnw.fm/PACR

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CanadianCannabisWire is part of the InvestorBrandNetwork.

420 with CNW — Canadian Researchers to Receive $4 Million to Develop Better Marijuana Breeds

Although the nascent cannabis industry is among the fastest-growing sectors in the world, it is plagued by challenges. For instance, because cultivating, researching and selling cannabis was prohibited for decades, cultivars have limited genetic knowledge and breeding resources. This puts the industry at a severe disadvantage against other crops that have undergone genetic research and experimentation to create superior genetics.

However, thanks to $4.2 million in federal, provincial and industry funding, this may soon be a thing of the past. Awarded to researchers at the University of British Columbia (“UBC”), the grant will be used to study enhanced cannabis cultivars with a particular focus on disease resistance. Dubbed Fast-Tracking Breeding of Powdery Mildew-Resistant Cannabis, the study will be led by UBC researchers Loren Rieseberg and Marco Todesco in partnership with Greg Baute and Charles Pick of Canadian-based Aurora Cannabis.

According to study leader Rieseberg, the plan is “to develop a genomics-enabled breeding pipeline that will increase the speed and precision of cannabis improvement and bridge the gap in genetic knowledge and breeding resources that currently separates cannabis from other crops.” One of the group’s main focuses will be to create genetics that are resistant to powdery mildew, a common fungal disease that is difficult to get rid of and can destroy cannabis crops.

“In collaboration with Aurora Cannabis, we’ll apply this pipeline to solving a major limiting factor to large-scale cannabis production, susceptibility to powdery mildew,” Rieseberg says. The ultimate goal is to establish a breeding pipeline of cultivars with “superior agronomic performances” that are more resistant to powdery mildew, thus better suited for large-scale production.

“The Government of Canada is proud to support Canada’s world-leading stem cell and genomics research community,” said William Amos, parliamentary secretary to Navdeep Bains, the federal minister of Innovation, Science and Industry. “Today’s investment has the potential to save lives and come up with new ways of solving environment and agricultural challenges. This is Canadian science and innovation in action.”

The funding was provided by Genome Canada, a nonprofit organization funded by the federal government. Approximately $15.4 million in federal funding will be provided to support 10 genomics research projects across the country focusing on health, agriculture and the environment, with additional funding worth more than $56 million coming from provincial governments, businesses and research partners.

“The results of this project will benefit the Canadian cannabis industry and Canadian consumers, but also basic and applied science,” says Todesco. “The genomic resources that will be generated as part of this project will be freely available to the scientific community and will help us and other researchers to understand better this important crop and its evolution.”

Pac Roots Cannabis Corp. (CSE: PACR) is an interesting player in the cannabis space that you should watch. The company focuses on leveraging top-tier genetics to develop premium marijuana products and strains.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — DEA Seeks Contractor with Capacity to Burn Tons of Cannabis Daily

Recently, the Drug Enforcement Administration (“DEA”) reached out for help to assist in burning about 1,000 pounds of cannabis per hour for eight hours straight. Each year, the DEA seizes tons of raw marijuana and millions of cannabis plants, which are usually destroyed. The contractor that performs this is responsible to oversee the burning of cannabis as well as other controlled substances that have been confiscated as evidence in drug cases.

The DEA stated that it would inspect the incinerator used in the process to ensure that no drug residue remained. The work description was posted earlier this month in a “sources sought notice.”

The post states that the description was not a request and doesn’t require the government to award a contract. It goes on to add that the DEA is carrying out market research and encourages all businesses, small and large scale, to respond to the notice. The statement that accompanies the post provides a behind-the-scenes view of how the DEA destroys the seized drugs.

Normal boxes are said to weigh between 40 to 60 pounds but can weigh four to five times that. The contraband may also come in on forklifts, cargo vans, tractor trailers and semi-trucks.

The description adds that the drugs are usually tightly packed “bales” or ‘”bricks” and are packaged in various materials, including oil/grease, plastic evidence bags, packing tape, plastic wrap, wrapping paper, cardboard and others. Contractors are expected to destroy the packaging as well.

There must be no smoke buildup, and proper ventilation is needed in order to avoid potential contact highs. Other mandates include regular drug checks for all personnel, mandatory background checks, and the careful placement of closed-circuit cameras that record the entire process of destroying the contraband. It should be noted that the DEA reserves the right to access these cameras.

Contractors and armed DEA agents will be in attendance on days that burning has been scheduled. Additionally, the contractor and on-site personnel will be required to hold all the information acquired under the DEA contract private. The information provided should only be used in performing the tasks outlined in the contract and should not be disclosed in any manner.

The work description concludes by stating that the work would start on January 1, 2021, and the contract would expire in 2026 — unless it is terminated sooner. The deadline to send in information for any contractor that would like to apply for the job was October 23.

Pac Roots Cannabis Corp. (CSE: PACR) is a cannabis industry player that you need to watch. This company focuses on growing hemp and marijuana whose genetics have been carefully selected to yield premium products.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Senators Say DEA Rule on THC Content of Hemp Contravenes Congressional Intent

In August, the Drug Enforcement Administration (“DEA”) unveiled proposed rules that would officially put the agency in line with the 2018 farm bill. The legislation legalized the cultivation and sale of industrial hemp and its extracts, allowing farmers across the country to grow hemp under state and tribal programs. However, the federal agency’s interim final rule on hemp has been met with resistance from activists who argue it contradicts the 2018 farm bill and will hamper the growth of the nascent hemp industry.

Last week, a pair of Oregon senators sent a letter to the DEA demanding changes to its proposed hemp regulations. Senators Ron Wyden and Jeff Merkley say that despite the DEA’s claim that its interim final rule (IFR) is only about compliance, the proposal “does significantly more.”

“The IFR treats hemp as a Schedule I controlled substance at any point its THC content exceeds 0.3% THC,” they write. Delta-9 THC is the main component responsible for cannabis’s psychoactive effects, and the 2018 farm bill requires that legal hemp has less than 0.3% delta-9 THC. “However, when Congress passed the 2018 farm bill, we understood that the intermediate stages of hemp processing can cause hemp extracts to temporarily exceed 0.3% THC, which is why we defined hemp based on its delta-9 THC level.

“In effect, the IFR criminalizes the intermediate steps of hemp processing, which is wholly inconsistent with Congress’s clearly stated purpose and text of the 2018 Farm Bill,” the letter continued.

According to the DEA’s proposed rules, businesses that produce hemp products may find themselves breaking the law, and they could be subject to enforcement actions if THC levels increase beyond 0.3%, even temporarily. Additionally, the DEA’s regulation states that all “synthetically derived tetrahydrocannabinols remain schedule I controlled substances,” locking out delta-8 THC. Delta-8 THC is converted from CBD through the use of a catalyst, a process that could be interpreted as a synthetic production process, making delta-8 THC illegal.

This is the second time the DEA has received a congressional request concerning its interim final rule on hemp. On October 20, nine members of Congress also sent a letter to the agency urging it to revise its proposed hemp regulations. Led by Reps David Joyce and Denver Riggleman, the members of Congress argued that the DEA’s provision which stated that “any such material that contains greater than 0.3% of delta-9 THC on a dry weight basis remains controlled in Schedule I.

“Our offices have received countless calls from constituents involved in the hemp industry who are extremely fearful that simply following the provisions of the Farm Bill will result in criminal liability under the IFR,” the letter continues. “The IFR will likely have the effect of inhibiting these nascent state hemp programs, thereby harming those American companies and workers who chose to pursue careers in the hemp industry and made significant investments to effectuate those aspirations.”

Pac Roots Cannabis Corp. (CSE: PACR) is an interesting company you should watch in the marijuana industry. The company focuses on using high-end and selectively bred genetics to produce premium marijuana products.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Marijuana Dispensary Workers Shoot Two Suspected Robbers

An attempted robbery that took place on Tuesday, Oct. 20, in a medical cannabis dispensary in Detroit went south for the suspects. Instead of becoming victims, the dispensary workers put up a fight. Two workers opened fire inside the facility on the three armed suspects who were trying to rob the store. As a result, two of the three suspects received nonlife-threatening injuries and were arrested; they are now recovering at a local hospital under police custody. The third suspect escaped.

Detroit Police Department Capt. Ian Severy stated that the crime was brazen, taking place in the middle of the day on a busy street. He added that it was fortunate that more people were not hurt.

The police say the three men burst into the Puff-N-Pass Lounge located in Detroit’s west side on Dexter Avenue and W. Chicago, at approximately 1 p.m. in the afternoon. After the three perpetrators entered the store, one of them started pistol whipping a 29-year old store employee. It was at this point that the owner of the facility emerged from another room, and shots were exchanged between the two parties.

Police confirmed that the worker and the 47-year old dispensary owner shot at the three suspects; one of them holds a concealed pistol license. Two of the three would-be robbers were shot while a third fled the scene, losing a shoe in the process. The two injured suspects were detained at the scene until police arrived; they were then taken into custody.

The police are calling on the third suspect to surrender to the authorities. Severy asserted that department officers are closing in on him and requested that he turn himself in, to help bring the crime to a safe conclusion.

The investigation is ongoing, and the police say investigators interviewed the two men at the dispensary who had shot at the robbers, concluding that they were acting in self-defense.

This robbery comes two years after a security guard who was working in a medical cannabis dispensary in Detroit was shot and killed during a gunfire exchange on the property.

Pac Roots Cannabis Corp. (CSE: PACR) is an interesting company you should watch. The company specializes in using a genetics-based approach to produce premium-grade marijuana products and strains.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Marijuana Could Alleviate OCD Symptoms, New Research Suggests

As cannabis becomes more mainstream, news about its medical capabilities are almost a daily occurrence. While the hype surrounding the controversial plant has definitely outpaced the science, preliminary findings have been encouraging. Plenty of people have used cannabis to manage everything from chronic pain and inflammation to stress and anxiety. According to new research, cannabis may be able to alleviate symptoms of Obsessive-Compulsive Disorder (OCD) as well.

OCD is a mental illness that causes repeated unwanted thoughts or fears that lead to compulsive behaviors. According to the new study published in the “Journal of Affective Disorders,” inhaling cannabis may yield temporary relief from the symptoms of OCD. Researchers with Washington State University worked with 87 individuals self-identifying with OCD. The participating patients “tracked the severity of their intrusions, compulsions, and/or anxiety immediately before and after 1,810 cannabis use sessions spanning a period of 31 months,” reports a study abstract.

According to the researchers, “patients reported a 60% reduction in compulsions, a 49% reduction in anxiety from before to after inhaling cannabis. Higher concentrations of CBD and higher doses predicted larger reductions in compulsions. The number of cannabis use sessions across time predicted changes in intrusions, such that later cannabis use sessions were associated with smaller reductions in intrusions (unwanted thoughts or impulses). Baseline symptom severity and dose remained fairly constant over time.

“Using a large dataset of medical cannabis users self-medicating for symptoms of OCD, we found that for the vast majority of cannabis use sessions, individuals reported reductions in intrusions, compulsions or anxiety,” researchers wrote. “Results indicated that after inhaling cannabis, ratings of intrusions were reduced by 49%, compulsions by 60%, and anxiety by 52%.”  The authors surmised that although inhaling cannabis may, in fact, reduce the symptoms of OCD, “results indicate that cannabis may have short-term, but not long-term beneficial effects on symptoms of OCD.”

The authors of the study say they sought to discover three things in their research: whether symptoms of OCD significantly reduced after inhaling cannabis; predictors (gender, dose, cannabis constituents, time) of these symptom changes; and “potential long-term consequences of using cannabis to self-medicate for OCD symptoms, including changes in dose and baseline symptom severity over time.”

However, the researchers concede that their study had its weaknesses, including the fact that the 87 participants were “self-selected, self-identified as having OCD, and there was no placebo control group. The study has still been met with support from cannabis advocates as it adds to the growing body of cannabis research. Few studies have assessed the potential efficacy of cannabis for the mitigation of symptoms of OCD,” says NORML’s Deputy Director Paul Armentano.

“As such, these findings, though somewhat limited by the study’s design, indicate that cannabis, and in particular, varieties high in CBD, holds promise as a therapeutic option for OCD patients and should be examined in a more rigorously designed controlled setting.”

The blossoming cannabis sector has resulted in the creation of numerous companies to address the needs of consumers and patients. One interesting company to watch in this space is Pac Root Cannabis Corp. (CSE: PACR), which focuses on using high-end genetics to make premium products in the marijuana and hemp space.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Cannabis Giant Unveils Plans to Promote Responsible Marijuana Marketing

Despite being federally prohibited, the state-legal U.S. cannabis industry is already worth millions of dollars in sales and experts project immense growth over the next decade. However, before that happens, the industry still has a lot of kinks to work out, especially cannabis marketing. Cannabis’s status as a controlled substance coupled with the fact that it lacks a comprehensive regulatory structure has resulted in dishonest, unreliable marketing that sometimes even seems to target underage consumers.

As the state-legal industry continues to grow, Cresco Labs, a vertically integrated, publicly-traded company that operates in nine states, is planning on pushing new advertising standards that would completely change how cannabis products are advertised. On October 6, the vertically integrated cannabis company released a proposal to convince other competitors in the cannabis space to adopt the same, or similar rules for homogeneity.

For instance, the proposal pledges to never show when marketing a cannabis product a “consumer lacking physical or mental control over their behavior, movement, or speech as a result of consuming cannabis,” as it seems to encourage overconsumption of cannabis products, “We will never suggest over-consumption is in any way acceptable, fun or desirable,” the proposal states.

Additionally, the rules also ban using a “symbol, image or language that is of primary appeal to those under the legal age, with Cresco putting guardrails on its media buys and experiential activities and taking “every reasonable measure to avoid contact with those under the legal age of consumption.”

In establishing such rules and putting forth high advertising standards for cannabis companies to adhere to, Cresco is hoping to open up more media inventory to run their ads. Since cannabis is still considered illegal at the federal level, publicly traded companies such as Facebook and Twitter do not accept paid cannabis ads, forcing cannabis businesses to rely on privately held media brands.

Cresco, for instance, has been able to buy ads with privately held media brands controlled by Condé Nast, Penske Media, and Vice Media, according to Cory Rothschild, senior VP of marketing for Cresco Labs. By advancing these advertising rules, he says, Cresco hopes to grow that list to media brands like Pandora and Sports Illustrated.

“It’s understandable why publishers would be cautious to move into this space. What we hope to demonstrate is that there are standards and values that we share, that the entire industry shares, that we can all commit to.”

Experts that this initiative is likely to be welcomed by established marijuana firms like Pac Roots Cannabis Corp. (CSE: PACR).

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Mississippi Governor Enacts Bill Allowing FDA-Approved Cannabis Medicines

Barely weeks before voters in Mississippi decide which of the competing medical marijuana initiatives before them will pass, the state governor has signed a bill that will allow FDA-approved medical cannabis products, such as Epidiolex, to be available to qualifying patients in the state.

By enacting this new law, Gov. Tate Reeves (R) has complicated the subject of medical marijuana legalization a little more.

For starters, the governor has been opposed to any plan to legalize medical marijuana in the state. To him, such a step would make marijuana a mainstream product, and that is a possibility he is unwilling to see happen under his watch.

Additionally, Initiative 65 sponsored by Mississippians for Compassionate Care met all the requirements to be included on the November ballot, and campaigns are underway to mobilize voters to cast their ballots in favor of this measure.

Under Initiative 65, patients with one of the proposed 22 qualifying conditions, such as cancer, chronic pain and seizures would be allowed to get a prescription from a doctor and possess up to 2.5 ounces of medical marijuana within a two-week window.

However, another competing measure will also be on the November ballot. This second measure was drafted by the legislature and it is seen as a more strict legalization law which doesn’t have a lot of the provisions in Initiative 65.

There are fears that voters could be confused by these two conflicting medical marijuana legalization measures, and that confusion could disadvantage Initiative 65. This fear gets more credence when you consider the fact that the American Medical Association, alongside the Mississippi State Medical Association, have widely circulated a sample ballot paper which gives voters directions on how to reject Initiative 65.

Observers say the governor may have had less than noble intentions when he signed the bill removing FDA-approved cannabis-based medicines from the state’s controlled substances law. It is believed that the intention of that law is to mislead voters into thinking that the state has already legalized medical marijuana, so there is no urgent need for them to support Initiative 65.

The team behind Initiative 65 therefore has a lot of work to do before success can be theirs, but they can at least count on the opinion polls which indicate that the population of voters in Mississippi overwhelmingly supports their legalization initiative. For example, a recent survey gives the measure 81% voter support.

Entities like Pac Roots Cannabis Corp. (CSE: PACR) probably think that the outcome of the voting may be too close to call given the different factors surrounding what is at stake.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.